Japanese encephalitis virus (JEV), which is transmitted to humans by mosquitoes, causes the serious neurological disorder Japanese encephalitis (JE). The fatality rate of JE is approximately 30 % and each year 30 000-50 000 clinical cases of JE and 10 000 deaths are reported, mainly in China, South East Asian countries, and India (Tsai, 2000) . Most cases of JE occur in South, East and South East Asia; however, JE cases have been reported in northern areas of Australia in recent decades (Hanna et al., 1996) . JEV belongs to the genus Flavivirus within the family Flaviviridae and is now classified into five genotypes (genotypes I-V) based on genomic RNA homology (Uchil & Satchidanandam, 2001; Solomon et al., 2003) . JEV has a single-stranded, positive-sense RNA genome. The approximately 11 kb genome contains one ORF encoding three structural proteins [capsid (C), premembrane (prM) and envelope (E)] and seven non-structural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5), as well as 59 and 39 NTRs (Lindenbach et al., 2007) . The E protein, the main structural protein, has a putative receptor-binding domain and neutralization epitopes. The E protein is thought to play major roles in determining viral pathogenicity by defining cell tropism and mediating entry into susceptible cells (Lindenbach et al., 2007; Gubler et al., 2007) . Since the early 1990s, various attempts have been made to clarify the molecular basis of JEV virulence by comparing the nucleotide sequences of virus strains with different degrees of virulence (Nitayaphan et al., 1990; Aihara et al., 1991; Cecilia & Gould, 1991; Hasegawa et al., 1992; Sumiyoshi et al., 1995; Chen et al., 1996; Ni & Barrett, 1996 , 1998 Arroyo et al., 2001; Wu et al., 2003; Lee et al., 2004; Chambers et al., 2007; Pujhari et al., 2011; Wu et al. 2011) . Some of these reports have suggested that nucleotide substitutions in the E protein may alter the virulence of JEV. Studies using an infectious clone of JEV demonstrated that a single glutamic acid-to-lysine substitution at position 138 of the E protein attenuated the JEV strain in which it was made (Sumiyoshi et al., 1995; Zhao et al., 2005; Liang et al., 2009) . It has also been reported that a single methionine-to-lysine substitution at position 279 of 3These authors contributed equally to this work. the E protein increases the virulence in mice of a JEV/ yellow fever virus chimera (Monath et al., 2002) . Recently, we reported that amino acid position 123 of the E protein determined the growth properties and pathogenicity of JEV (Tajima et al., 2010) . Several additional studies have shown that mutations in other coding and non-coding regions are also critical for virus replication and pathogenesis in the mouse model (Mori et al., 2005; Chambers et al., 2007; Kim et al., 2008; Wu et al., 2011) .
In recent years, we have isolated JEV from pigs and characterized the JEV strains prevalent in Japan (Nerome et al., 2007) . Among these new isolates, isolate Mie/40/2004 showed high virulence relative to other genotype I isolates (Nerome et al., 2007) (Table 1) . Genetic analysis showed no differences in the deduced amino acid sequences of the E proteins among the four genotype I isolates, indicating that the E region is not responsible for the higher virulence of Mie/40/2004 (Nerome et al., 2007 . To determine the amino acid differences among the high-and low-virulence strains, we first compared the full amino acid sequence of Mie/40/2004 (GenBank accession no. AB241118) to that of Mie/41/2002 (GenBank accession no. AB241119), the least virulent of the new genotype I isolates (Nerome et al., 2007) (Table 1) . Seven amino acid differences were detected between these two strains, four of which were found in the NS5 protein (positions 20, 429, 526 and 860) and one each in the C (position 10), NS3 (position 467) and NS4A (position 3) proteins. We then compared the amino acid residues at the seven divergent positions to Mie40 and were observed for 2 weeks (Table 2, experiment 1). Mouse challenge experiments were performed in accordance with the fundamental rules for animal experiments of our S467N and rJEV-Mie41-NS4A V3I , which have, respectively, a serine-to-asparagine mutation at position 467 (S467N) in the NS3 region of Mie/41/2002 and a valine-to-isoleucine mutation at position three (V3I) in the NS4A region of Mie/41/2002 (Fig. 1a) . Groups of mice (n510) were inoculated with 1610 3 p.f.u. of recombinant virus ( Our previous findings suggest that the virulence of JEV in mice correlates with its growth properties in vitro (Tajima et al., 2010) . Therefore, we examined the growth properties of Mie/41/2002, Mie/40/2004 and rJEV-Mie41-NS4A V3I in cultured cells. We first compared the plaque sizes of the strains as previously described (Tajima et al., 2010) . The plaque morphologies of all three viruses were similar (Fig.  1b) , indicating that the V3I mutation does not affect plaque formation and that the difference in virulence between Mie/41/2002 and Mie/40/2004 strains does not correlate with their plaque sizes in Vero cells. We next compared the growth rates of the three strains in four cell lines as previously described (Tajima et al., 2010) . In Vero cells, the growth curves were very similar in all three viruses (Fig. 1c) . No difference was observed among the growth curves in human lung adenocarcinoma A549 cells (Fig. 1d) , which are often used to study the type 1 interferon (IFN) response to flavivirus infection (Muñoz-Jordan et al., 2003) , or in mouse hepatoma Hepa 1-6 cells (Fig. 1e) , which can also respond to type 1 IFN (data not shown). We also examined the growth kinetics of the three viruses in IFN-b-pretreated A549 cells, and no significant difference was observed among the growth curves of the viruses ( Supplementary Fig. S1 , available in JGV Online). As we have shown previously that there is a good correlation between virulence in vivo and the growth characteristics of JEV in mouse neuroblastoma-derived N18 cells (Tajima et al., 2010) , we analysed the growth kinetics of our viruses in N18 cells. However, even in N18 cells, the growth rates of Mie/40/2004 and rJEV-Mie41-NS4A V3I resembled that of Mie/41/2002 (Fig. 1f) . These results indicate that there is no significant difference between the growth properties of the high-virulence Mie/40/2004 and rJEV-Mie41-NS4A V3I viruses and those of the low-virulence Mie/41/2002 virus.
In the present paper, we have attempted to identify the amino acid in Mie/40/2004 that is responsible for its higher pathogenicity in mice. Amino acid sequence comparisons between the highly virulent Mie/40/2004 and other less virulent JEV strains suggested that an amino acid at position 3 of the NS4A protein is a determinant of pathogenicity in the mouse model. Reverse-genetics protein alters viral pathogenicity in mice. Interestingly, the V3I substitution had no effect on the in vitro growth properties of the virus, and we failed to gain insight into the mechanism by which the amino acid substitution alters the virulence of JEV. Flavivirus NS4A is a small hydrophobic protein that localizes to the sites of viral RNA replication and interacts with a member of the replication complex, NS1, suggesting that NS4A is a component of the flaviviral replication complex and plays a role in viral RNA replication (Lindenbach & Rice, 1999; Mackenzie et al., 1998; Westaway et al., 2003; Miller et al., 2007) . Previous findings suggest that NS4A induces the membrane rearrangements necessary to form the viral replication complex (Roosendaal et al., 2006; Miller et al., 2007) . NS4A consists of an N-terminal hydrophilic region (aa 1-50) and several hydrophobic transmembrane regions (aa 51-150) (Miller et al., 2007) . We recently demonstrated that the N-terminal region of dengue type 1 virus (DENV-1) NS4A is indispensable for the replication of DENV-1 (Tajima et al., 2011) . The critical position 3 of JEV NS4A is located in the N-terminal region. A recent report showed that, in West Nile virus, the N-terminal region of NS4A functions as a cofactor of NS3 and regulates the ATPase activity of the NS3 helicase, which is required for unwinding viral RNA during viral replication (Shiryaev et al., 2009) . This finding raises the possibility that the amino acid variation at position 3 of NS4A may affect the interaction between NS4A and NS3. However, our data showed that the amino acid difference at position 3 did not influence the growth rate of JEV in cultured cells, suggesting that this polymorphism does not influence a basic replication function such as the interaction between NS3 and NS4A. The site of Ile-3 is also part of the NS3-NS4A cleavage-site sequence, which is cleaved by the viral serine protease (NS2B-NS3 complex). However, the V3I mutation did not alter the growth properties of JEV in vitro, indicating that the mutation does not affect the processing of the NS3-NS4A junction. NS4A also weakly inhibits the IFN signalling pathway (Muñoz-Jordan et al., 2003; Lin et al., 2008) . DEAD-box RNA helicase DDX42 interacts with JEV NS4A and is able to overcome the JEVinduced antagonism of IFN responses, supporting the idea that NS4A modulates the IFN pathway (Lin et al., 2008) . Although the region of NS4A that interacts with DDX42 is unknown, it is possible that the amino acid at position 3 participates in the binding of NS4A to DDX42. However, in the data presented, there was no difference in growth rates among the three strains in IFN-responsive A549 cells, suggesting that the V3I mutation may not affect IFN signalling pathways. Therefore, the mechanism by which the NS4A V3I mutation increases JEV virulence seems to be complex. In vivo studies on the growth kinetics of the high-and low-virulence viruses and the immune responses to viruses are essential to understand the role of the amino acid residue at position 3 of NS4A. The mutant rJEV-Mie41-NS4A V3I exhibited slightly weaker virulence than did Mie/40/2004 (Table 2; 
